$RHHBY

AI Analysis

Generated on May 11, 2026

AI Score
72/ 100
Hold$RHHBY

Roche Holding AG

$RHHBYOTCHealthcareMega-Cap

Roche is a global leader in pharmaceuticals and diagnostics with leading oncology and immunology franchises.

Market Cap
$210.0B
Revenue (TTM)
$63.0B
+2.0%
Net Income (TTM)
$12.0B
+5.0%
EPS (TTM)
$3.50
P/E Ratio
16.0
Dividend Yield
3.0%
52-Week Range
$30-$42
Beta
0.35
Dimension Scores
Fundamental
74
Technical
66
Sentiment
70
Risk / Reward
76
Momentum
62
FundTechSentRiskMome
Financial Health
Profitability
79strong
Growth
65moderate
Liquidity
84strong
Solvency
76strong
Efficiency
72strong

Valuation, technical analysis, investment thesis, risk assessment and more for $RHHBY

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.